BioCardia Inc.

NASDAQ:BCDA  
4.32
-0.08 (-1.82%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)71.22M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.03 Million
Adjusted EPS-$0.21
See more estimates
10-Day MA$4.33
50-Day MA$3.91
200-Day MA$3.39
See more pivots

BioCardia Inc. Stock, NASDAQ:BCDA

125 Shoreway Road, Suite B, San Carlos, California 94070
United States of America
Phone: +1.650.226.0120
Number of Employees: 29

Description

BioCardia, Inc. operates as a clinical-stage regenerative medicine company. It develops novel therapeutics for cardiovascular diseases. The firm offers proprietary comprehensive biotherapeutic solutions for cardiovascular disease under the CardiAMP and CardiALLO brand. It operates in only one business segment, which is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The company was founded on January 12, 1994 and is headquartered in San Carlos, CA.